Loading...
Loading...
Among the 6 tracked institutional investors we monitor, LTRN (LANTERN PHARMA INC) is held with a combined value of $1.49M across 619,460 shares. The largest holder is VANGUARD GROUP INC with a position worth $1.16M (0.00% of their portfolio). 2 funds opened new positions in the most recent quarter. 2 funds increased their holdings.
Total Institutional Value
$1.49M
Total Shares Held
619,460
Institutional Holders
6
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $1.16M | 0.00% | New |
| 2 | RENAISSANCE TECHNOLOGIES LLC | $158.92K | 0.00% | +5.1% |
| 3 | Voss Capital, LP | $68.50K | 0.00% | - |
| 4 | BlackRock, Inc. | $62.02K | 0.00% | +2.3% |
| 5 | STATE STREET CORP | $32.40K | 0.00% | - |
| 6 | FMR LLC | $685 | 0.00% | New |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of LTRN with a position worth $1.16M, representing 0.00% of their portfolio. In total, 6 institutional investors hold LTRN with a combined value of $1.49M.
In the most recent quarter, 2 funds opened a new position in LTRN. Additionally, 2 increased their holdings.
Institutional investors hold $1.49M worth of LTRN stock across 6 positions. The largest institutional holder is VANGUARD GROUP INC with $1.16M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For LTRN, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their LTRN positions.